Bentley Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/08 Q1

ended 12/31/07 FY 2007 – amended

ended 12/31/07 FY 2007

ended 09/30/07 Q3

ended 06/30/07 Q2

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

King Luther Capital Management Corp

Robinson Edward J

McGovern Michael

News Filter

Pharmaceuticals’ Stockholders Approve Merger Agreement

Notifies NYSE of Intention to Delist Common Stock

& Teva Pharmaceutical Industries LTD. Merger Consideration Established at $14.82 Per Share

Unaudited Pro Forma Condensed Consolidated Financial Information

Board Approves Spin-Off of Drug Delivery Business

Proxies Filter

Proxy related to merger

Preliminary proxy related to merger

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Confidential treatment order